Page 4 - Discovery Services News Today

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital, from its main shareholders, including Mr. Philippe Genne, Founder of Oncodesign Services, as well as certain key shareholders and several managers and minority shareholders, follow...

Operator: Greetings, and welcome to the Inotiv, Inc.s Fourth Quarter and Full Year Fiscal 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Uh oh.

CHICAGO, Nov. 4, 2022 /PRNewswire/ -- Recombinant Proteins Market size is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period

/PRNewswire/ -- Recombinant Proteins Market size is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the...

Charles River Laboratories International, Inc. (NYSE:NYSE:CRL) Q3 2022 Earnings Conference Call November 2, 2022 09:00 AM ET Company Participants Todd Spencer - VP, IR James Foster -...

Drug Discovery Services Market to Register 14.5% CAGR by 2032 | Future Market Insights

Join our data scientist panel and legal experts for an informative and deep dive discussion into the realm of “Intelligence” in our industry and thoughts on which predictive solutions...

In this eye-opening presentation, one of the nation’s most experienced journalists shares how she gets to the source of what’s happening behind-the-scenes, how well the American public is being served by today’s media and political environment, and how future elections will impact what lies beyond the beltway.

Editor’s Note: On August 31, 2022, HaystackID shared an educational webcast on the topic of data mining in data breach incident response. As data mining has increasingly become one of...